miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Simona Caporali(Istituto Dermopatico dell'Immacolata), Stefania D’Atri(Istituto Dermopatico dell'Immacolata)
Cited by 84
Related Papers
Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
|International Journal of Oncology|2016|72
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
|Journal of Translational Medicine|2012|39